Bartosz Wasag, Els Lierman, Peter Meeus, Jan Cools, Peter Vandenberghe. The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11). Haematologica 2011;96(6):922-926; https://doi.org/10.3324/haematol.2010.036558.